Adtalem Global Education (NYSE:CVSA) SVP Sells $358,810.00 in Stock

Adtalem Global Education Inc. (NYSE:CVSA) SVP Douglas Beck sold 2,650 shares of Adtalem Global Education stock in a transaction on Tuesday, July 7th. The shares were sold at an average price of $135.40, for a total value of $358,810.00. Following the completion of the transaction, the senior vice president owned 35,509 shares of the company’s stock, valued at approximately $4,807,918.60. The trade was a 6.94% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Performance

Adtalem Global Education stock traded down $0.68 on Friday, reaching $130.64. The company’s stock had a trading volume of 301,004 shares, compared to its average volume of 347,922. The company’s fifty day moving average is $124.72. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.70 and a current ratio of 0.70. The stock has a market capitalization of $4.45 billion, a P/E ratio of 20.35, a price-to-earnings-growth ratio of 0.99 and a beta of 0.62. Adtalem Global Education Inc. has a twelve month low of $86.97 and a twelve month high of $156.26.

Adtalem Global Education (NYSE:CVSA) last announced its earnings results on Thursday, May 7th. The company reported $1.98 earnings per share for the quarter, beating analysts’ consensus estimates of $1.73 by $0.25. Adtalem Global Education had a return on equity of 20.19% and a net margin of 12.26%.The company had revenue of $487.03 million during the quarter. During the same quarter last year, the business posted $1.92 earnings per share. The business’s quarterly revenue was up 4.5% compared to the same quarter last year. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. As a group, equities analysts forecast that Adtalem Global Education Inc. will post 8.04 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on CVSA shares. Wall Street Zen raised shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a research note on Saturday, June 13th. Weiss Ratings reissued a “hold (c+)” rating on shares of Adtalem Global Education in a report on Friday, May 22nd. Zacks Research cut shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 25th. Truist Financial upped their price objective on Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, May 11th. Finally, Barrington Research reiterated an “outperform” rating and issued a $170.00 price objective on shares of Adtalem Global Education in a research report on Monday, June 8th. Two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, Adtalem Global Education presently has a consensus rating of “Moderate Buy” and an average target price of $155.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.